SCHEMBL8209469

SCHEMBL8209469

CC(C)Oc1cccc(CN2CCC3(CC2)C(=O)N(Cc2ncnn2Cc2ccccc2)C(=O)N3c2cccc(F)c2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 12/20 0.43
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
MCHR1 Q99705 5/20 0.38
CACNA1F O60840 1/20 0.38
CHRM2 P08172 1/20 0.38
ADRB1 P08588 1/20 0.38
DRD2 P14416 1/20 0.38
SLC6A2 P23975 1/20 0.38
ADRA1D P25100 1/20 0.38
ADRA1A P35348 1/20 0.38
HRH1 P35367 1/20 0.38
ADRA1B P35368 1/20 0.38
OPRM1 P35372 1/20 0.38
DRD3 P35462 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
OPRL1 P41146 1/20 0.38
CACNA1D Q01668 1/20 0.38
SLC6A3 Q01959 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479606 0.89 BACE1 (0.54) BACE1
SCHEMBL8203685 0.82 BACE1 (0.44) BACE1MEN1KMT2ACACNA1FCHRM2
SCHEMBL8203989 0.82 BACE1 (0.43) BACE1MEN1KMT2AMCHR1CACNA1F
SCHEMBL3479603 0.80 BACE1 (0.53) BACE1
SCHEMBL3479523 0.80 BACE1 (0.53) BACE1
SCHEMBL8197624 0.76 BACE1 (0.51) BACE1MEN1KMT2AMCHR1CACNA1F
SCHEMBL593029 0.75 BACE1 (0.43) BACE1MEN1KMT2ACACNA1FCHRM2
SCHEMBL15146194 0.74 BACE1 (0.45) BACE1MEN1KMT2AMCHR1CACNA1F
SCHEMBL3479518 0.74 BACE1 (0.54) BACE1
SCHEMBL594221 0.74 BACE1 (0.49) BACE1MEN1KMT2ACACNA1FCHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008030412-A2 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2008-03-13 WO disclosed